Risedronate Sodium 35 MG [Actonel]
ATN_PMO_IV
Approved small_molecule completed
Quick answer
Risedronate Sodium 35 MG [Actonel] for Postmenopausal Osteoporosis is a Approved program (small_molecule) at Dong Wang with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dong Wang
- Indication
- Postmenopausal Osteoporosis
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed